{
    "Trade/Device Name(s)": [
        "IgG"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K162208",
    "Predicate Device Reference 510(k) Number(s)": [
        "K073490"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFN",
        "JJE"
    ],
    "Summary Letter Date": "November 29, 2016",
    "Summary Letter Received Date": "November 30, 2016",
    "Submission Date": "January 6, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D, and E immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "IgG"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Cerebrospinal fluid"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "AU400",
        "AU400e",
        "AU480",
        "AU600",
        "AU640",
        "AU640e",
        "AU680",
        "AU2700",
        "AU5400",
        "AU5800",
        "DxC 700 AU"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetry"
    ],
    "Methodologies": [
        "Immunoturbidimetric assay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Beckman Coulter IgG immunoturbidimetric assay for quantitative measurement of IgG on AU and DxC 700 AU analyzers",
    "Indications for Use Summary": "Quantitative determination of IgG immunoglobulins in human serum, plasma, and cerebrospinal fluid on Beckman Coulter AU analyzers to aid in diagnosing abnormal protein metabolism and immune deficiency",
    "fda_folder": "Immunology"
}